NYSE ARCA | ETF
The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index.
The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies" products and services.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 3.05% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.95% |
| AXGN | Axogen Inc | Healthcare | Medical Devices | 2.94% |
| GRAL | GRAIL, LLC | Healthcare | Diagnostics & Research | 2.72% |
| STAA | STAAR Surgical Company | Healthcare | Medical Instruments & Supplies | 2.48% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.46% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 2.30% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 2.18% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.17% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.17% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 2.13% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 2.05% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.03% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.03% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.95% |
| IQV | IQVIA Holdings Inc | Healthcare | Diagnostics & Research | 1.94% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.85% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 1.83% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 1.81% |
| PKI | PerkinElmer Inc | Healthcare | Diagnostics & Research | 1.77% |